[logo] HealthTree Foundation
search person

What is the ASCO Conference?

Posted: May 27, 2024
What is the ASCO Conference? image

The American Society of Clinical Oncology (ASCO) holds a yearly conference in June to allow researchers and doctors in the cancer community an opportunity to share their research on the newest developments in treatments, technologies, and more for cancers like myelofibrosis.

This year, the conference will be held from May 31st to June 4th, 2024 at McCormick Place in Chicago, Illinois. HealthTree looks forward to meeting with myelofibrosis specialists to cover the latest and greatest insights about myelofibrosis and its care options. Following the event, expect to see HealthTree News articles and HealthTree University videos sharing what we learned at ASCO from myelofibrosis specialists. 

We have found that patients who educate themselves about the facets of their disease can be better advocates for themselves and receive improved care and quality of life. Stay tuned for upcoming ASCO content to learn about the latest in myelofibrosis research. 

Parts of the ASCO Conference 

The conference features a variety of sessions, including:

  • Research presentations: Here, doctors and researchers unveil their latest findings in cancer treatment and management. These presentations are often the culmination of extensive research and clinical trials. Research findings are presented in the following formats: 
    • Oral presentations: Researchers share their studies and data through formal speeches, often accompanied by visual aids like slideshows
    • Poster sessions: Researchers display their findings on posters, offering a more interactive format where attendees can engage directly with the presenters to discuss the research in depth.
  • Educational sessions: These sessions aim to update medical professionals on the current best practices and new approaches in the treatment of different types of cancers. 
  • Networking events: These events provide a platform for oncology specialists to connect, discuss, and potentially collaborate on future projects.

Can Patients Go to ASCO? 

While the ASCO conference is mainly for medical professionals, researchers, and allied health providers, patients can attend if they register. However, it's important to note that the technical nature of the presentations might be challenging for non-medical professionals to understand fully. 

HealthTree will write about topics discussed at the conference and share them with the HealthTree community in the form of HealthTree News articles and HealthTree University videos. This will help make information easy for patients to understand. 

Subscribe to our newsletter and stay tuned for upcoming ASCO content! 

Join the HealthTree for Myelofibrosis Newsletter to Learn More! 

We invite you to click the button below to subscribe to the HealthTree for myelofibrosis newsletter and stay updated on the latest advancements in myelofibrosis. 

JOIN THE HEALTHTREE FOR Myelofibrosis NEWSLETTER

The American Society of Clinical Oncology (ASCO) holds a yearly conference in June to allow researchers and doctors in the cancer community an opportunity to share their research on the newest developments in treatments, technologies, and more for cancers like myelofibrosis.

This year, the conference will be held from May 31st to June 4th, 2024 at McCormick Place in Chicago, Illinois. HealthTree looks forward to meeting with myelofibrosis specialists to cover the latest and greatest insights about myelofibrosis and its care options. Following the event, expect to see HealthTree News articles and HealthTree University videos sharing what we learned at ASCO from myelofibrosis specialists. 

We have found that patients who educate themselves about the facets of their disease can be better advocates for themselves and receive improved care and quality of life. Stay tuned for upcoming ASCO content to learn about the latest in myelofibrosis research. 

Parts of the ASCO Conference 

The conference features a variety of sessions, including:

  • Research presentations: Here, doctors and researchers unveil their latest findings in cancer treatment and management. These presentations are often the culmination of extensive research and clinical trials. Research findings are presented in the following formats: 
    • Oral presentations: Researchers share their studies and data through formal speeches, often accompanied by visual aids like slideshows
    • Poster sessions: Researchers display their findings on posters, offering a more interactive format where attendees can engage directly with the presenters to discuss the research in depth.
  • Educational sessions: These sessions aim to update medical professionals on the current best practices and new approaches in the treatment of different types of cancers. 
  • Networking events: These events provide a platform for oncology specialists to connect, discuss, and potentially collaborate on future projects.

Can Patients Go to ASCO? 

While the ASCO conference is mainly for medical professionals, researchers, and allied health providers, patients can attend if they register. However, it's important to note that the technical nature of the presentations might be challenging for non-medical professionals to understand fully. 

HealthTree will write about topics discussed at the conference and share them with the HealthTree community in the form of HealthTree News articles and HealthTree University videos. This will help make information easy for patients to understand. 

Subscribe to our newsletter and stay tuned for upcoming ASCO content! 

Join the HealthTree for Myelofibrosis Newsletter to Learn More! 

We invite you to click the button below to subscribe to the HealthTree for myelofibrosis newsletter and stay updated on the latest advancements in myelofibrosis. 

JOIN THE HEALTHTREE FOR Myelofibrosis NEWSLETTER

The author Megan Heaps

about the author
Megan Heaps

Megan joined HealthTree in 2022. She enjoys helping patients and their care partners understand the various aspects of the cancer. This understanding enables them to better advocate for themselves and improve their treatment outcomes. 

newsletter icon

Get the latest thought leadership on your Myeloproliferative Neoplasm delivered straight to your inbox

Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.